Improving synthesis prediction of small molecules at scale with RetroChimera
The paper describes the model’s architecture as well as extensive validation studies, including the model’s ability to recall rare reaction types, and successful zero-shot transfer and fine-tuning on proprietary datasets. We open-source RetroChimera’s implementation and weights in the hope that it will enable researchers to accelerate development of new medicinally relevant molecules and advanced materials. Developing new medicines and materials requires making new molecules but planning how to make them is still largely manual, time-consuming, and costly.
- ▪The paper describes the model’s architecture as well as extensive validation studies, including the model’s ability to recall rare reaction types, and successful zero-shot transfer and fine-tuning on proprietary datasets.
- ▪We open-source RetroChimera’s implementation and weights in the hope that it will enable researchers to accelerate development of new medicinally relevant molecules and advanced materials.
- ▪Developing new medicines and materials requires making new molecules but planning how to make them is still largely manual, time-consuming, and costly.
Microsoft Research files mainly under ai. We currently carry 11 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Microsoft Research |
| Canonical URL | https://www.microsoft.com/en-us/research/blog/improving-synthesis-prediction-of-small-molecules-at-scale-with-retrochimera/ |
| Publication time | Mon, 21 Sep 2026 15:30:19 +0000 |
| Retrieval time | 2026-09-21T15:33:48.834Z |
| Last seen | 2026-09-21T15:33:48.834Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | wXCvXCvgTmY0 · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Improving synthesis prediction of small molecules at scale with RetroChimera Published September 21, 2026 By Guoqing Liu , Senior Researcher Felix Pultar , Senior Research Scientist John Gardner , Senior Researcher Marwin Segler , Senior Principal Research Manager Share this page Share on Facebook Share on X Share on LinkedIn Share on Reddit Subscribe to our RSS feed At a glance We report on the recent publication of our retrosynthesis model RetroChimera in the journal Nature. The paper describes the model’s architecture as well as extensive validation studies, including the model’s ability to recall rare reaction types, and successful zero-shot transfer and fine-tuning on proprietary datasets.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Microsoft Research.
Discussion
0 commentsMore from Microsoft Research
